Clinical Research Organizations Procurement Intelligence Report, 2024 - 2030 (Revenue Forecast, Supplier Ranking & Matrix, Emerging Technologies, Pricing Models, Cost Structure, Engagement & Operating Model, Competitive Landscape)

Research Scope & Content Outline

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Research Methodology
                    1.3. Research Scope & Assumption
                    1.4. Information Procurement
                         1.4.1. Purchased Database
                         1.4.2. GVR’s Internal Database
                         1.4.3. Secondary Sources & Third-Party Perspectives
                         1.4.4. Primary Research
                    1.5. Information Analysis
                         1.5.1. Data Analysis Models
                    1.6. Market Formulation & Data Visualization
                    1.7. Data Validation & Publishing
Chapter 2. Clinical Research Organizations Market Intelligence
                    2.1. Category Definition
                    2.2. Category Intelligence
                         2.2.1. Market Size
                         2.2.2. Trends
                         2.2.3. Drivers
                         2.2.4. Challenges
                         2.2.5. Segmental Outlook
                         2.2.6. Regional Outlook
                    2.3. Technology
                         2.3.1. Emerging Technology
                         2.3.2. Best Practices in the Industry
                    2.4. Regulatory Landscape
                    2.5. Porter’s Five Forces Analysis
                         2.5.1. Bargaining power of suppliers
                         2.5.2. Bargaining power of buyers
                         2.5.3. Threat of substitutes
                         2.5.4. Threat of new entrants
                         2.5.5. Competitive rivalry
Chapter 3. Clinical Research Organizations Market Supplier Intelligence
                    3.1. Identification of top 12 service providers
                         3.1.1. Asymchem Inc.
                         3.1.2. Charles River Laboratories International, Inc.
                         3.1.3. Dalton Pharma Services
                         3.1.4. ICON plc
                         3.1.5. IQVIA Inc.
                         3.1.6. Parexel International (MA) Corporation
                         3.1.7. Pharmaron
                         3.1.8. Piramal Pharma Limited
                         3.1.9. Sun Pharmaceutical Industries Ltd.
                         3.1.10. Syneos Health, Inc.
                         3.1.11. Thermo Fisher Scientific, Inc.
                         3.1.12. WuXi AppTec Co., Ltd.
                    3.2. Clinical Research Organizations Supply Chain Analysis
                    3.3. Clinical Research Organizations Supplier Landscape
                    3.4. Clinical Research Organizations Supplier Ranking Methodology
                         3.4.1. Supplier Operational Capabilities
                              3.4.1.1. Geographical Service Provision
                              3.4.1.2. Years in Service
                              3.4.1.3. Employee Strength
                              3.4.1.4. Revenue Generated
                              3.4.1.5. Key Clients
                              3.4.1.6. Certifications
                         3.4.2. Supplier Functional Capabilities
                              3.4.2.1. Patient Management
                                   3.4.2.1.1. Patient Recruitment
                                   3.4.2.1.2. Patient Retention
                                   3.4.2.1.3. Patient Monitoring
                                   3.4.2.1.4. Others
                              3.4.2.2. Site Management
                                   3.4.2.2.1. Site Recruitment
                                   3.4.2.2.2. Site Retention
                                   3.4.2.2.3. Site Monitoring
                                   3.4.2.2.4. Others
                              3.4.2.3. Others
                                   3.4.2.3.1. Physician Recruitment
                                   3.4.2.3.2. Data Management
                                   3.4.2.3.3. Regulatory Affairs Management
                    3.5. Clinical Research Organizations Supplier Scoring Criteria
                    3.6. Clinical Research Organizations Supplier Positional Matrix (SPM)
                         3.6.1. Rulers
                         3.6.2. Challengers
                         3.6.3. Loungers
                         3.6.4. Niches
                    3.7. Clinical Research Organizations Supplier Market Concentration
                         3.7.1. Industry structure
                    3.8. Recommended Clinical Research Organizations Service Providers
                         3.8.1. Supplier 1 with detailed profile
                         3.8.2. Supplier 2 with detailed profile
                         3.8.3. Supplier 3 with detailed profile
Chapter 4. Competitive Landscape
                    4.1. Recent Supplier Developments with Measured Impact
                         4.1.1. Joint Ventures
                         4.1.2. Mergers & Acquisitions
                         4.1.3. Collaborations or Partnerships
                         4.1.4. Other major developments
                    4.2. Supply-Demand Analysis
                         4.2.1. Supply Analysis
                         4.2.2. Demand Analysis
Chapter 5. Clinical Research Organizations Pricing and Cost Intelligence
                    5.1. Total Cost Structure Overview
                         5.1.1. Clinical Procedure
                         5.1.2. Site Management and Monitoring
                         5.1.3. Patient Recruitment and Management
                         5.1.4. Data Management
                         5.1.5. Insurance, Tax, and Profit
                         5.1.6. Others
                    5.2. Pricing Intelligence
                         5.2.1. Factors Influencing the Rates for Clinical Research
                         5.2.2. Average Cost of Clinical Trials by Key Therapeutic Area
                         5.2.3. Raw Material Price Trend
                         5.2.4. Pricing Model Analysis
                              5.2.4.1. Cost plus or,
                              5.2.4.2. Volume based or,
                              5.2.4.3. Value based or,
                              5.2.4.4. Dynamic pricing model or,
                              5.2.4.5. Competitive pricing model or,
                              5.2.4.6. Others
                         5.2.5. Clinical Research Rates - Service Provider’s Quotation
Chapter 6. Sourcing Intelligence
                    6.1. Engagement Model
                         6.1.1. Fully Outsourcing Model or,
                         6.1.2. Partial/Hybrid Outsourcing Model or,
                         6.1.3. In-house Product Development Model or,
                         6.1.4. Shared Service Model
                    6.2. Operating Model
                         6.2.1. Basic Provider or,
                         6.2.2. Approved Provider or,
                         6.2.3. Performance-based Model or,
                         6.2.4. Others
                    6.3. KPI/SLA Elements
                    6.4. Negotiation Strategies
                    6.5. LCC/BCC Sourcing Analysis
                         6.5.1. China
                         6.5.2. India
                         6.5.3. U.S.
                         6.5.4. Japan
                         6.5.5. U.K.
                         6.5.6. Insights on top 2 LCC/BCC Countries
                    6.6. Average Cost of Conducting Clinical Trials in China